Neuroprotective Effects of Lithium - Pointing out Protein Phosphatases as Drug Targets?

Author(s): A. Mora, G. Sabio, F. Centeno

Journal Name: Current Medicinal Chemistry - Central Nervous System Agents
Continued as Central Nervous System Agents in Medicinal Chemistry

Volume 3 , Issue 4 , 2003


Lithium, which has been used in the psychiatric domain for many years, is showing interesting properties as a neuroprotective agent against different apoptotic insults. These neuroprotective effects have been explained by its action in signaling pathways implicated in apoptosis and cell survival. Studying the action of lithium in these signaling pathways, emerging data show lithium as an inhibitor of the dephosphorylation events. The importance of phosphorylation and dephosphorylation in intracellular signaling pathways has been long recognized, although attention has focused mainly on kinases, which have become the second most important group of drug targets. However, recent studies are highlighting the importance of serine / threonine protein phosphatases in apoptosis. The effect of lithium on serine / threonine protein phosphatases needs further study, but lithium is pointing out these enzymes as potential targets for novel therapeutics against neurodegenerative diseases.

Keywords: lithium, apoptosis, phosphatases, kinases

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [335 - 339]
Pages: 5
DOI: 10.2174/1568015033477668
Price: $65

Article Metrics

PDF: 1